Improved survival in pediatric heart transplant recipients: Have white, black and hispanic children benefited equally?

American Journal of Transplantation

Volumn 11, Issue 1, 2011, Pages 120-128

  Singh, T P ^a,b   Almond, C S ^a,b   Gauvreau, K ^a,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Disparities; heart transplantation; pediatrics; race; survival

Indexed keywords

ADOLESCENT; ARTICLE; CAUCASIAN; CHILD; FEMALE; GRAFT FAILURE; HEALTH CARE DISPARITY; HEART TRANSPLANTATION; HISPANIC; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEGRO; NEWBORN; PEDIATRIC SURGERY; PRESCHOOL CHILD; PRIORITY JOURNAL; RACE DIFFERENCE; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

EID: 78650913844     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03357.x     Document Type: Article

References (38)

1. Krieger N, Rehkopf DH, Chen JT, Waterman PD, Marcelli E, Kennedy M,. The fall and rise of US inequities in premature mortality: 1960-2002. PLoS Med 2008; 5: e46.
2. Mechanic D,. Policy challenges in addressing racial disparities and improving population health. Health Aff (Millwood) 2005; 24: 335-338.
3. Chin MH, Alexander-Young M, Burnet DL,. Health care quality-improvement approaches to reducing child health disparities. Pediatrics 2009; 124 (Suppl. 3): S224-S236.
4. Chin MH, Walters AE, Cook SC, Huang ES,. Interventions to reduce racial and ethnic disparities in health care. Med Care Res Rev 2007; 64 (Suppl. 5): 7S-28S.
5. Stanley A, DeLia D, Cantor JC,. Racial disparity and technology diffusion: The case of cardioverter defibrillator implants, 1996-2001. J Natl Med Assoc 2007; 99: 201-207.
6. Chin C, Naftel DC, Singh TP, et al,. Risk factors for recurrent rejection in pediatric heart transplantation: A multicenter experience. J Heart Lung Transplant 2004; 23: 178-185.
7. Pahl E, Naftel DC, Canter CE, Frazier EA, Kirklin JK, Morrow WR,. Death after rejection with severe hemodynamic compromise in pediatric heart transplant recipients: A multi-institutional study. J Heart Lung Transplant 2001; 20: 279-287.
8. Webber SA, Naftel DC, Parker J, et al,. Late rejection episodes more than 1 year after pediatric heart transplantation: Risk factors and outcomes. J Heart Lung Transplant 2003; 22: 869-875.
9. Mahle WT, Kanter KR, Vincent RN,. Disparities in outcome for black patients after pediatric heart transplantation. J Pediatr 2005; 147: 739-743.
10. Boucek MM, Aurora P, Edwards LB, et al,. Registry of the international society for heart and lung transplantation: Tenth official pediatric heart transplantation report-2007. J Heart Lung Transplant 2007; 26: 796-807. (Pubitemid 47199083)
11. Boucek MM, Waltz DA, Edwards LB, et al,. Registry of the International Society for Heart and Lung Transplantation: Ninth official pediatric heart transplantation report-2006. J Heart Lung Transplant 2006; 25: 893-903.
12. Singh TP, Edwards LB, Kirk R, Boucek MM,. Era effect on post-transplant survival adjusted for baseline risk factors in pediatric heart transplant recipients. J Heart Lung Transplant 2009; 28: 1285-1291.
13. Schwartz GJ, Haycock GB, Edelmann CM, Jr,., Spitzer A,. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263.
14. Girnita DM, Webber SA, Ferrell R, et al,. Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation 2006; 82: 1774-1780.
15. Hesselink DA, van Gelder T, van Schaik RH, et al,. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes. Clin Pharmacol Ther 2004; 76: 545-556.
16. Singh TP, Gauvreau K, Bastardi HJ, Blume ED, Mayer JE,. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circ Heart Fail 2009; 2: 160-165.
17. Rose G,. Strategy of prevention: Lessons from cardiovascular disease. Br Med J (Clin Res Ed) 1981; 282: 1847-1851.
18. Dellgren G, Koirala B, Sakopoulus A, et al,. Pediatric heart transplantation: Improving results in high-risk patients. J Thorac Cardiovasc Surg 2001; 121: 782-791.
19. Checchia PA, Larsen R, Sehra R, et al,. Effect of a selection and postoperative care protocol on survival of infants with hypoplastic left heart syndrome. Ann Thorac Surg 2004; 77: 477-483. Discussion 483.
20. Canter CE, Shaddy RE, Bernstein D, et al,. Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 115: 658-676.
21. Russo LM, Webber SA,. Pediatric heart transplantation: Immunosuppression and its complications. Curr Opin Cardiol 2004; 19: 104-109.
22. Kobashigawa JA, Kiyosaki KK, Patel, et al,. Benefit of immune monitoring in heart transplant patients using ATP production in activated lymphocytes. J Heart Lung Transplant 2010; 29: 504-508.
23. Rossano JW, Denfield SW, Kim JJ, et al,. Assessment of the Cylex ImmuKnow cell function assay in pediatric heart transplant patients. J Heart Lung Transplant 2009; 28: 26-31.
24. Bingler MA, Feingold B, Miller SA, et al,. Chronic high Epstein-Barr viral load state and risk for late-onset posttransplant lymphoproliferative disease/lymphoma in children. Am J Transplant 2008; 8: 442-445.
25. Singh TP, Gauvreau K, Bastardi H, Blume E, Mayer J,. Socioeconomic position and graft failure in pediatric heart transplant recipients. Circul Heart Fail 2009; 2: 160-165.
26. Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR,. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009; 9: 2597-2606.
27. Chavers BM, Snyder JJ, Skeans MA, Weinhandl ED, Kasiske BL,. Racial disparity trends for graft failure in the US pediatric kidney transplant population, 1980-2004. Am J Transplant 2009; 9: 543-549.
28. Hutchings A, Purcell WM, Benfield MR,. Increased costimulatory responses in African-American kidney allograft recipients. Transplantation 2001; 71: 692-695.
29. Gordon EJ, Ladner DP, Caicedo JC, Franklin J,. Disparities in kidney transplant outcomes: A review. Semin Nephrol 30: 81-89.
30. Kofler S, Bigdeli AK, Kaczmarek I, et al,. Long-term outcomes after 1000 heart transplantations in six different eras of innovation in a single center Transpl Int 2009; 22: 1140-1150.
31. Kobashigawa JA, Meiser BM,. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation. Transplantation 2005; 80 (2 Suppl): S235-S243.
32. Kobashigawa JA, Miller LW, Russell SD, et al,. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006; 6: 1377-1386.
33. Nelson AR,. Unequal treatment: Report of the Institute of Medicine on racial and ethnic disparities in healthcare. Ann Thorac Surg 2003; 76: S1377-S1381.
34. Oliver JD, 3rd, Neff RT, Leeser DB, et al,. Influence of race on kidney transplantation in the Department of Defense healthcare system. Am J Nephrol 2009; 29: 327-333.
35. Pamboukian SV, Costanzo MR, Meyer P, Bartlett L, McLeod M, Heroux A,. Influence of race in heart failure and cardiac transplantation: Mortality differences are eliminated by specialized, comprehensive care. J Card Fail 2003; 9: 80-86.
36. Schlotthauer AE, Badler A, Cook SC, Perez DJ, Chin MH,. Evaluating interventions to reduce health care disparities: An RWJF program. Health Aff (Millwood) 2008; 27: 568-573.
37. Singh TP, Gauvreau K, Thiagarajan R, Blume ED, Piercey G, Almond CS,. Racial and ethnic differences in mortality in children awaiting heart transplant in the United States. Am J Transplant 2009; 9: 2808-2815.
38. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM,. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med 1999; 341: 1661-1669.